Authors: ABBRUZZESE JL MADDEN T SUGARMAN SM ELLIS AL LOUGHLIN S HESS KR NEWMAN RA ZWELLING LA RABER MN

Citation: Jl. Abbruzzese et al., PHASE-I CLINICAL AND PLASMA AND CELLULAR PHARMACOLOGICAL STUDY OF TOPOTECAN WITHOUT AND WITH GRANULOCYTE-COLONY-STIMULATING FACTOR, Clinical cancer research, 2(9), 1996, pp. 1489-1497

Authors: SUGARMAN SM ZOU YY WASAN K POIROT K KUMI R REDDY S PEREZSOLER R

Citation: Sm. Sugarman et al., LIPID COMPLEXED CAMPTOTHECIN - FORMULATION AND INITIAL BIODISTRIBUTION AND ANTITUMOR-ACTIVITY STUDIES, Cancer chemotherapy and pharmacology, 37(6), 1996, pp. 531-538

Authors: JONES DV SUGARMAN SM MARKOWITZ AB LEVIN B ABBRUZZESE JL EVANS DB CHARNSANGAVEJ C SMITH R PATT YZ

Citation: Dv. Jones et al., CISPLATIN, 5-FLUOROURACIL, AND LEUCOVORIN IN THE THERAPY OF ADENOCARCINOMAS OF THE PANCREAS, Oncology Reports, 2(6), 1995, pp. 1121-1123

Authors: SINICROPE FA SUGARMAN SM

Citation: Fa. Sinicrope et Sm. Sugarman, ROLE OF ADJUVANT THERAPY IN SURGICALLY RESECTED COLORECTAL-CARCINOMA, Gastroenterology, 109(3), 1995, pp. 984-993

Authors: PAZDUR R LASSERE Y RHODES V AJANI JA SUGARMAN SM PATT YZ JONES DV MARKOWITZ AB ABBRUZZESE JL BREADY B LEVIN B

Citation: R. Pazdur et al., PHASE-II TRIAL OF URACIL AND TEGAFUR PLUS ORAL LEUCOVORIN - AN EFFECTIVE ORAL REGIMEN IN THE TREATMENT OF METASTATIC COLORECTAL-CARCINOMA, Journal of clinical oncology, 12(11), 1994, pp. 2296-2300